Hartline Investment Corp Laboratory Corp Of America Holdings Transaction History

Hartline Investment Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$203.72 - $248.97 $631,532 - $771,807	3,100 New	3,100 $729,000
Q4 2020 Feb 09, 2021	SELL	$186.91 - $214.42 $6,541 - $7,504	-35 Reduced 1.12%	3,100 $631,000
Q3 2020 Nov 10, 2020	SELL	$167.03 - $201.3 $25,054 - $30,195	-150 Reduced 4.57%	3,135 $590,000
Q3 2017 Nov 20, 2017	BUY	$149.47 - $160.56 $491,008 - $527,439	3,285	3,285 $496,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Hartline Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Hartline Investment Corp with notifications on news.